Literature DB >> 26599135

Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.

Bjørn H Ebdrup1, Jayachandra M Raghava1, Mette Ø Nielsen1, Egill Rostrup1, Birte Glenthøj1.   

Abstract

BACKGROUND: Psychotic symptoms are core clinical features of schizophrenia. We tested recent hypotheses proposing that psychotic, or positive, symptoms stem from irregularities in long-range white matter tracts projecting into the frontal cortex, and we predicted that selective dopamine D2/3 receptor blockade would restore white matter.
METHODS: Between December 2008 and July 2011, antipsychotic-naive patients with first-episode schizophrenia and matched healthy controls underwent baseline examination with 3 T MRI diffusion tensor imaging and clinical assessments. We assessed group differences of fractional anisotropy (FA) using voxelwise tract-based spatial statistics (TBSS) and anatomic region of interest (ROI)-based analyses. Subsequently, patients underwent 6 weeks of antipsychotic monotherapy with amisulpride. We repeated the examinations after 6 weeks.
RESULTS: We included 38 patients with first-episode schizophrenia and 38 controls in our analysis, and 28 individuals in each group completed the study. At baseline, whole brain TBSS analyses revealed lower FA in patients in the right anterior thalamic radiation (ATR), right cingulum, right inferior longitudinal fasciculus and right corticospinal tract (CT). Fractional anisotropy in the right ATR correlated with positive symptoms (z = 2.64, p= 0.008). The ROI analyses showed significant associations between positive symptoms and FA of the frontal fasciculi, specifically the right arcuate fasciculus (z = 2.83, p= 0.005) and right superior longitudinal fasciculus (z = -3.31, p= 0.001). At re-examination, all correlations between positive symptoms and frontal fasciculi had resolved. Fractional anisotropy in the ATR increased more in patients than in controls (z = -4.92, p< 0.001). The amisulpride dose correlated positively with FA changes in the right CT (t= 2.52, p= 0.019). LIMITATIONS: Smoking and a previous diagnosis of substance abuse were potential confounders. Long-term effects of amisulpride on white matter were not evaluated.
CONCLUSION: Antipsychotic-naive patients with schizophrenia displayed subtle deficits in white matter, and psychotic symptoms appeared specifically associated with frontal fasciculi integrity. Six weeks of amisulpride treatment normalized white matter. Potential remyelinating effects of dopamine D2/3 receptor antagonism warrant further clarification.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26599135      PMCID: PMC4764482          DOI: 10.1503/jpn.150030

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  60 in total

1.  The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys.

Authors:  Karl-Anton Dorph-Petersen; Joseph N Pierri; James M Perel; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

2.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

3.  Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change.

Authors:  Alan Anticevic; Xinyu Hu; Yuan Xiao; Junmei Hu; Fei Li; Feng Bi; Michael W Cole; Aleksandar Savic; Genevieve J Yang; Grega Repovs; John D Murray; Xiao-Jing Wang; Xiaoqi Huang; Su Lui; John H Krystal; Qiyong Gong
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

4.  A depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; B Schissel
Journal:  Schizophr Res       Date:  1990 Jul-Aug       Impact factor: 4.939

5.  In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.

Authors:  George Bartzokis; Po H Lu; Stephanie B Stewart; Bolanle Oluwadara; Andrew J Lucas; Joanna Pantages; Erika Pratt; Jonathan E Sherin; Lori L Altshuler; Jim Mintz; Michael J Gitlin; Kenneth L Subotnik; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-17       Impact factor: 4.939

Review 6.  Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage.

Authors:  Peter Kochunov; L Elliot Hong
Journal:  Schizophr Bull       Date:  2014-05-27       Impact factor: 9.306

Review 7.  White matter development in the early stages of psychosis.

Authors:  Bart D Peters; Katherine H Karlsgodt
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

8.  N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia.

Authors:  Alan Anticevic; Philip R Corlett; Michael W Cole; Aleksandar Savic; Mark Gancsos; Yanqing Tang; Grega Repovs; John D Murray; Naomi R Driesen; Peter T Morgan; Ke Xu; Fei Wang; John H Krystal
Journal:  Biol Psychiatry       Date:  2014-07-31       Impact factor: 13.382

Review 9.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

10.  Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations.

Authors:  Ben Smith; David G Fowler; Daniel Freeman; Paul Bebbington; Hannah Bashforth; Philippa Garety; Graham Dunn; Elizabeth Kuipers
Journal:  Schizophr Res       Date:  2006-07-20       Impact factor: 4.939

View more
  16 in total

1.  Differential Time Course of Microstructural White Matter in Patients With Psychotic Disorder and Individuals at Risk: A 3-Year Follow-up Study.

Authors:  Patrick Domen; Sanne Peeters; Stijn Michielse; Ed Gronenschild; Wolfgang Viechtbauer; Alard Roebroeck; Jim van Os; Machteld Marcelis
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

2.  Individual differences in social desirability are associated with white-matter microstructure of the external capsule.

Authors:  Milan Andrejević; Dar Meshi; Wouter van den Bos; Hauke R Heekeren
Journal:  Cogn Affect Behav Neurosci       Date:  2017-12       Impact factor: 3.282

3.  White matter microstructure in schizophrenia patients with a history of violence.

Authors:  Natalia Tesli; Lars T Westlye; Guttorm B Storvestre; Tiril P Gurholt; Ingrid Agartz; Ingrid Melle; Ole A Andreassen; Unn K Haukvik
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-29       Impact factor: 5.270

4.  Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.

Authors:  Johanna Seitz-Holland; Suheyla Cetin-Karayumak; Matcheri Keshavan; Marek Kubicki; Joanne D Wojcik; Amanda Lyall; James Levitt; Martha E Shenton; Ofer Pasternak; Carl-Fredrik Westin; Madhura Baxi; Sinead Kelly; Raquelle Mesholam-Gately; Mark Vangel; Godfrey Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Yogesh Rathi
Journal:  Mol Psychiatry       Date:  2021-01-22       Impact factor: 13.437

5.  Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis.

Authors:  Pontus Plavén-Sigray; Pauliina Ikonen Victorsson; Alexander Santillo; Granville J Matheson; Maria Lee; Karin Collste; Helena Fatouros-Bergman; Carl M Sellgren; Sophie Erhardt; Ingrid Agartz; Christer Halldin; Lars Farde; Simon Cervenka
Journal:  Mol Psychiatry       Date:  2021-11-10       Impact factor: 13.437

6.  Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.

Authors:  N Bak; B H Ebdrup; B Oranje; B Fagerlund; M H Jensen; S W Düring; M Ø Nielsen; B Y Glenthøj; L K Hansen
Journal:  Transl Psychiatry       Date:  2017-04-11       Impact factor: 6.222

7.  A 16-week randomized placebo-controlled trial investigating the effects of omega-3 polyunsaturated fatty acid treatment on white matter microstructure in recent-onset psychosis patients concurrently treated with risperidone.

Authors:  Amanda E Lyall; Felix L Nägele; Ofer Pasternak; Juan A Gallego; Anil K Malhotra; Robert K McNamara; Marek Kubicki; Bart D Peters; Delbert G Robinson; Philip R Szeszko
Journal:  Psychiatry Res Neuroimaging       Date:  2020-11-04       Impact factor: 2.376

Review 8.  The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies.

Authors:  Chengmin Yang; Jing Tang; Naici Liu; Li Yao; Mengyuan Xu; Hui Sun; Bo Tao; Qiyong Gong; Hengyi Cao; Wenjing Zhang; Su Lui
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

9.  Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia.

Authors:  Simon Anhøj; Mette Ødegaard Nielsen; Maria Høj Jensen; Kristin Ford; Birgitte Fagerlund; Peter Williamson; Birte Glenthøj; Egill Rostrup
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

10.  The impact of schizophrenia and intelligence on the relationship between age and brain volume.

Authors:  Maria H Jensen; Nikolaj Bak; Egill Rostrup; Mette Ø Nielsen; Christos Pantelis; Birte Y Glenthøj; Bjørn H Ebdrup; Birgitte Fagerlund
Journal:  Schizophr Res Cogn       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.